UK markets open in 7 hours 48 minutes
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.20 (-0.25%) GOLD FUTURES
2,425.60 -0.30 (-0.01%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
55,226.66 +295.43 (+0.54%)
United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 12.19B |
| Enterprise value | 10.08B |
| Trailing P/E | 13.01 |
| Forward P/E | 11.70 |
| PEG ratio (5-yr expected) | 0.81 |
| Price/sales (ttm) | 5.47 |
| Price/book (mrq) | 2.28 |
| Enterprise value/revenue | 4.03 |
| Enterprise value/EBITDA | 6.74 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.54 |
| 52-week change 3 | 27.05% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 279.98 |
| 52-week low 3 | 204.44 |
| 50-day moving average 3 | 244.91 |
| 200-day moving average 3 | 231.46 |
Share statistics
| Avg vol (3-month) 3 | 527.07k |
| Avg vol (10-day) 3 | 450.49k |
| Shares outstanding 5 | 44.37M |
| Implied shares outstanding 6 | 44.37M |
| Float 8 | 40.64M |
| % held by insiders 1 | 1.85% |
| % held by institutions 1 | 104.13% |
| Shares short (30 Apr 2024) 4 | 3.85M |
| Short ratio (30 Apr 2024) 4 | 7.74 |
| Short % of float (30 Apr 2024) 4 | 11.46% |
| Short % of shares outstanding (30 Apr 2024) 4 | 8.68% |
| Shares short (prior month 28 Mar 2024) 4 | 4.89M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 2:1 |
| Last split date 3 | 23 Sept 2009 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 42.05% |
| Operating margin (ttm) | 52.57% |
Management effectiveness
| Return on assets (ttm) | 12.25% |
| Return on equity (ttm) | 20.08% |
Income statement
| Revenue (ttm) | 2.5B |
| Revenue per share (ttm) | 53.18 |
| Quarterly revenue growth (yoy) | 33.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.31B |
| Net income avi to common (ttm) | 1.05B |
| Diluted EPS (ttm) | 21.12 |
| Quarterly earnings growth (yoy) | 27.30% |
Balance sheet
| Total cash (mrq) | 2.71B |
| Total cash per share (mrq) | 61.05 |
| Total debt (mrq) | 600M |
| Total debt/equity (mrq) | 11.24% |
| Current ratio (mrq) | 3.78 |
| Book value per share (mrq) | 120.76 |
Cash flow statement
| Operating cash flow (ttm) | 979.7M |
| Levered free cash flow (ttm) | 578.84M |
© 2024 Yahoo. All rights reserved.